UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Small-cell lung cancer: what we know, what we need to know and the path forward

Nature reviews. Cancer, 2017-12, Vol.17 (12), p.725-737

2017

Volltextzugriff (PDF)

Mechanical regulation of glycolysis via cytoskeleton architecture

Nature (London), 2020-02, Vol.578 (7796), p.621-626

2020

Volltextzugriff (PDF)

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

PloS one, 2009-07, Vol.4 (7), p.e6146-e6146

2009

Volltextzugriff (PDF)

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Cell reports (Cambridge), 2016-08, Vol.16 (5), p.1259-1272

2016

Volltextzugriff (PDF)

Lung Cancer Computational Biology and Resources

Cold Spring Harbor perspectives in biology, 2022-02, Vol.12 (2), p.a038273

2022

Volltextzugriff (PDF)

Molecular Biology of Lung Cancer: Clinical Implications

Clinics in chest medicine, 2011-12, Vol.32 (4), p.703-740

2011

Volltextzugriff (PDF)

A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients

Clinical cancer research, 2013-03, Vol.19 (6), p.1577-1586

2013

Volltextzugriff (PDF)

Small cell lung cancer: will recent progress lead to improved outcomes?

Clinical cancer research, 2015-05, Vol.21 (10), p.2244-2255

2015

Volltextzugriff (PDF)

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

Cancer cell, 2010-12, Vol.18 (6), p.548-551

2010

Volltextzugriff (PDF)

AP-1 leads the way in lung cancer transformation

Developmental cell, 2022-02, Vol.57 (3), p.292-294

2022

Volltextzugriff (PDF)

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Clinical cancer research, 2013-11, Vol.19 (22), p.6322-6328

2013

Volltextzugriff (PDF)

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Nature reviews. Cancer, 2019-05, Vol.19 (5), p.289-297

2019

Volltextzugriff (PDF)

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis

Cell reports (Cambridge), 2016-08, Vol.16 (6), p.1614-1628

2016

Volltextzugriff (PDF)

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

The Journal of clinical investigation, 2016-09, Vol.126 (9), p.3219-3235

2016

Volltextzugriff (PDF)

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13), p.3251-3267

2019

Volltextzugriff (PDF)

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Human mutation, 2014-06, Vol.35 (6), p.756-765

2014

Volltextzugriff (PDF)

NRF2 regulates serine biosynthesis in non-small cell lung cancer

Nature genetics, 2015-12, Vol.47 (12), p.1475-1481

2015

Volltextzugriff (PDF)

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells

Molecular cell, 2019-12, Vol.76 (5), p.838-851.e5

2019

Volltextzugriff (PDF)

Proteomics: A new dimension to decode small cell lung cancer

Cell, 2024-01, Vol.187 (1), p.14-16

2024

Volltextzugriff (PDF)

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Nature (London), 2017-06, Vol.546 (7656), p.168-172

2017

Volltextzugriff (PDF)

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

PloS one, 2012-06, Vol.7 (6), p.e39167-e39167

2012

Volltextzugriff (PDF)

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

PloS one, 2009-10, Vol.4 (10), p.e7464-e7464

2009

Volltextzugriff (PDF)

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.768-777

2015

Volltextzugriff (PDF)

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (7), p.djw295

2017

Volltextzugriff (PDF)

High-throughput functional evaluation of human cancer-associated mutations using base editors

Nature biotechnology, 2022-06, Vol.40 (6), p.874-884

2022

Volltextzugriff (PDF)

1 – 25 von 1.598

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.508)
Mit Volltextzugriff
(1.466)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.586)
Schwedisch
(7)
Russisch
(4)
Japanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(986)
Humans
(866)
Life Sciences & Biomedicine
(803)
Oncology
(495)
Lung Neoplasms - Genetics
(331)
Female
(327)
Biological And Medical Sciences
(316)
Lung Cancer
(275)
Male
(263)
Medical Sciences
(263)
Tumors
(263)
Animals
(240)
Lung Neoplasms - Pathology
(218)
Mutation
(198)
Cell Line, Tumor
(197)
Carcinoma, Non-Small-Cell Lung - Genetics
(182)
Middle Aged
(171)
Mice
(168)
Science & Technology - Other Topics
(164)
Multidisciplinary Sciences
(163)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.157)
MEDLINE
(934)
Publisher or Other Site
(650)
Ingenta
(518)
Journals@Ovid
(454)
IngentaConnect Journals
(250)
ScienceDirect
(216)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(148)
Nature_系列刊
(144)
Wiley Online Library
(134)
Nexis Uni
(108)
Wiley Online Library
(102)
Oxford journals
(71)
JSTOR
(68)
Springer journals
(62)
Oxford Journals 2020 Medicine
(60)
Psychology & Behavioral Sciences Collection (EBSCO)
(29)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(25)
Ebook Central Perpetual and DDA
(25)
SpringerLink Series
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Small-cell lung cancer: what we know, what we need to know and the path forward

Mechanical regulation of glycolysis via cytoskeleton architecture

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Lung Cancer Computational Biology and Resources

Molecular Biology of Lung Cancer: Clinical Implications

A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients

Small cell lung cancer: will recent progress lead to improved outcomes?

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

AP-1 leads the way in lung cancer transformation

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS -Mutant Lung Adenocarcinoma

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

NRF2 regulates serine biosynthesis in non-small cell lung cancer

Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells

Proteomics: A new dimension to decode small cell lung cancer

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

High-throughput functional evaluation of human cancer-associated mutations using base editors

Suchergebnisse filtern